Furthermore, a dual relationship can exist with some factors (e.g. obesity; TLR4 within the TME) initially offering protection to cancer development de novo but contributing to progression once malignancy is established. This evidence concerns the gene TLR4 and obesity due to melanocortin 4 receptor deficiency.